EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling

Madison Parrot iD, Nuo Xu, Md Adnan iD, Joseph Cave, Hamidreza Ghandehari iD, Elizabeth Nance iD, Venkata Yellepeddi iD

Bioengineering & Translational Medicine · 2026-11 · 11 (6)

DOI: 10.1002/btm2.70176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 08.09.2026. Verfasst von Madison Parrot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Pediatrics Spencer Fox Eccles School of Medicine, University of Utah Salt Lake City Utah USA. Die Arbeit nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles represent a major advancement in drug delivery, enhancing stability, solubility, and targeted delivery while reducing non‐specific toxicity. Despite promising preclinical results, few nanoparticle platforms have successfully translated to clinical use due to limited pharmacokinetic (PK) data, off‐target effects, manufacturing complexity, and a lack of long‐term studies. Emphasizing the pivotal role of PK in this development process is essential for harnessing the full therapeutic potential of nanoparticle applications in clinical practice. In this review, we introduce the concept of model‐informed nanoparticle development (MIND), an extension of model‐informed drug development (MIDD) principles to nanomedicine that integrates knowledge of nanoparticle interactions with biological systems and state‐of‐the‐art pharmacokinetic modeling to support evidence‐based decision‐making. Physiologically‐based PK (PBPK) models simulate the absorption, distribution, metabolism, and elimination (ADME) of nanoparticles within the body, incorporating physiological parameters to predict their PK behavior. Population‐based PK (PopPK) models utilize population variability to characterize nanoparticle PK across diverse patient groups, optimizing dosing strategies and personalized medicine approaches. Mechanistic models elucidate the intricate interactions between nanoparticles and biological systems, integrating cellular pathways and disease mechanisms to predict therapeutic outcomes and guide nanoparticle design. Through the MIND framework, these modeling approaches can enhance our understanding of nanoparticle PK, foster innovation in active agent delivery systems, and accelerate nanoparticle translation from research to clinical applications.

Schlagwörter

Stichwörter der Autor:innen

NanomedicinePBPKPK modelingPopPK modelingpharmacokineticstranslation

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Pediatrics Spencer Fox Eccles School of Medicine, University of Utah Salt Lake City Utah USA.
  • Department of Molecular Pharmaceutics Utah Center for Nanomedicine, College of Pharmacy, University of Utah Salt Lake City Utah USA.
  • Department of Chemical Engineering University of Washington Seattle WA USA.
  • Mathematics in Medicine Program, Houston Methodist Research Institute Houston Texas USA.
  • Physiology, Biophysics, and Systems Biology Program, Graduate School of Medical Sciences Weill Cornell Medicine New York New York USA.
  • Department of Biomedical Engineering, The John and Marcia Price College of Engineering University of Utah Salt Lake City Utah USA.

ORCID-Profile: Madison Parrot, Md Adnan, Hamidreza Ghandehari, Elizabeth Nance, Venkata Yellepeddi

Förderung

  • NIBIB NIH HHS
  • National Institutes of Health

Zitieren

APA

Parrot, M., Xu, N., Adnan, M., Cave, J., Ghandehari, H., Nance, E., & Yellepeddi, V. (2026). From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling. Bioengineering & Translational Medicine, 11(6). https://doi.org/10.1002/btm2.70176

Vancouver

Parrot M, Xu N, Adnan M, Cave J, Ghandehari H, Nance E, et al. From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling. Bioengineering & Translational Medicine. 2026;11(6). doi:10.1002/btm2.70176

BibTeX
@article{Parrot2026,
  author = {Parrot, Madison and Xu, Nuo and Adnan, Md and Cave, Joseph and Ghandehari, Hamidreza and Nance, Elizabeth and Yellepeddi, Venkata},
  title = {From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  volume = {11},
  number = {6},
  doi = {10.1002/btm2.70176}
}
Kostenlos starten →